AVEO - AVEO Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents24,42714,94915,09626,634
Short Term Investments-18,5768,2527,501
Net Receivables3,0264021,0274,641
Inventory----
Other Current Assets12616,0271,702467
Total Current Assets27,93550,18326,31540,376
Long Term Investments----
Property, plant and equipment---23
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets-15970143
Deferred Long Term Asset Charges----
Total Assets27,93550,19827,28540,542
Current Liabilities
Accounts Payable3,4992,4362,1861,425
Short/Current Long Term Debt3,254-2,1242,053
Other Current Liabilities1,95818,0085105,171
Total Current Liabilities18,11732,12410,34912,398
Long Term Debt15,77918,47711,8797,418
Other Liabilities21,26640,3606,9803,499
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities55,16290,96129,20823,315
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock1261187658
Retained Earnings-595,009-586,969-521,916-495,029
Treasury Stock1-46-3
Capital Surplus567,655546,092519,911512,201
Other Stockholder Equity1-46-3
Total stockholders' equity-27,227-40,763-1,92317,227
Net Tangible Assets-27,227-40,763-1,92317,227